Full Text
Budget Impact Analysis Of Darbepoetin Alfa Every 3 Weeks Versus Epoetin Alfa Every Week For Cancer Patients Receiving Chemotherapy From A Us Payer's Perspective

Abstract

Authors

N. McGarvey S. Shreay H. Xu P. Corey-Lisle

Back to Volume 16, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×